CapsoVision (NASDAQ:CV) Shares Gap Up – Here’s Why

CapsoVision, Inc. (NASDAQ:CV)’s share price gapped up before the market opened on Tuesday . The stock had previously closed at $11.58, but opened at $12.00. CapsoVision shares last traded at $12.52, with a volume of 24,823 shares traded.

Analysts Set New Price Targets

Several research firms have weighed in on CV. Weiss Ratings reiterated a “sell (e)” rating on shares of CapsoVision in a report on Monday, December 22nd. Roth Capital set a $7.00 price objective on CapsoVision in a report on Tuesday, November 4th. Zacks Research raised CapsoVision to a “hold” rating in a research note on Wednesday, November 5th. Finally, Benchmark reaffirmed a “speculative buy” rating on shares of CapsoVision in a research note on Friday, November 14th. One analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, one has given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $6.00.

CapsoVision Price Performance

The business’s 50-day moving average is $7.48.

CapsoVision (NASDAQ:CV) last issued its quarterly earnings data on Thursday, November 13th. The company reported ($0.17) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.03). The firm had revenue of $3.54 million during the quarter.

Institutional Trading of CapsoVision

An institutional investor recently bought a new position in CapsoVision stock. Citadel Advisors LLC acquired a new stake in CapsoVision, Inc. (NASDAQ:CV) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 23,735 shares of the company’s stock, valued at approximately $115,000. Citadel Advisors LLC owned 0.05% of CapsoVision as of its most recent filing with the Securities and Exchange Commission (SEC).

About CapsoVision

CapsoVision, Inc (NASDAQ: CV) is a medical device company specializing in advanced capsule endoscopy systems for gastrointestinal diagnostics. The company’s flagship product, the CapsoCam® Plus System, features a swallowable, tether-free capsule equipped with four side-viewing cameras that capture high-resolution, 360-degree images of the small intestine. By storing images internally rather than transmitting data wirelessly, CapsoCam Plus enables patients to maintain normal daily activities during the procedure and reduces the risk of signal loss or image drop-out.

In addition to its capsule hardware, CapsoVision offers CapsoCloud®, a secure, cloud-based platform that streamlines image retrieval, storage and reporting.